DataKnowledgeCloudtrainingcoordination

L1000 LINCS DCIC FIBR015 MCLF022CN 6H O24 purmorphamine 4uM.tsv.gz (File)

Taxon:

Homo sapiens

Taxon (Entity type)

Subject:

MCLF022CN

Subject (Entity type)

Project:

LINCS-2021

Project (Entity type)

File Format:

TSV

File Format (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Data Type:

gene expression profile

Data Type (Entity type)

Compression Format:

GZIP format

File Format (Entity type)

Biosample:

L1000 LINCS DCIC 2021 FIBR015 MCLF022CN 6H O24 purmorphamine 4uM

Biosample (Entity type)

Assay Type:

landmark transcript profiling assay

Assay Type (Entity type)

Uncompressed Size In Bytes:191 KB

Size In Bytes:89.7 KB

Sha256:41807862a78630a45e606a3c90fbefd35f2e311a604e048d4fe5efaf7ae31e53

Persistent Id:drs://drs.lincs-dcic.org/806223e86ae59bc6456698ecd9788882

Mime Type:application/gzip

Md5:806223e86ae59bc6456698ecd9788882

Filename:L1000_LINCS_DCIC_FIBR015_MCLF022CN_6H_O24_purmorphamine_4uM.tsv.gz

Creation Time:2021-01-21T00:00:00

Access Url:

drs://drs.lincs-dcic.org/806223e86ae59bc6456698ecd9788882

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 FIBR015 MCLF022CN 6H O24 purmorphamine 4uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 FIBR015 MCLF022CN 6H O24 purmorphamine 4uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.